deferoxamine has been researched along with chromium in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Hornbostel, H; Kaufmann, W; Siegenthaler, W | 1 |
| Luckey, M; Neilands, JB; Wayne, R | 1 |
| Christoffersen, J; Christoffersen, MR; Thyregod, HC | 1 |
| Snow, GA | 1 |
| Halstead, BW; Williams, DR | 1 |
| Dalal, NS; Kasprzak, KS; Shi, X | 1 |
| Dalal, NS; Liu, KJ; Shi, X | 1 |
| Gendron, R; Grenier, D; Mayrand, D; Sorsa, T; Uitto, VJ | 1 |
| Castranova, V; Leonard, S; Shi, X; Vallyathan, V; Wang, S; Zang, L | 1 |
| Furukawa, Y; Ishii, M; Kashimoto, T; Nishimura, Y; Sasaki, YF; Sugiyama, M; Susa, N; Ueda, J; Ueno, S; Yasuno, M; Yokoi, K | 1 |
| Antholine, WE; Jannetto, PJ; Myers, CR | 1 |
| Aiken, BA; Edwards, JA; McLoughlin, TJ; Pizza, FX; Tsivitse, SK | 1 |
| Tilbrook, L | 1 |
| Crawford, RL; Paszczynski, AJ; Zawadzka, AM | 1 |
| Bátka, D; Farkas, E; Kremper, G; Pócsi, I | 1 |
| Hernández-Pando, R; Medina-Campos, ON; Molina-Jijón, E; Pedraza-Chaverri, J; Pinzón, E; Tapia, E; Zarco-Márquez, G; Zataraín-Barrón, ZL; Zavaleta, RM | 1 |
| Dubbin, WE; Goh, TB | 1 |
| Carvalho, AAC; de Carvalho, GGA; Esposito, BP; Ghous, T; Nomura, CS; Rasheed, A | 1 |
1 review(s) available for deferoxamine and chromium
| Article | Year |
|---|---|
Chelating agents in medicine.
Topics: Aluminum; Cadmium; Chelating Agents; Chromium; Copper; Deferoxamine; Dimercaprol; Edetic Acid; Environmental Pollutants; Humans; Iron; Mercury; Metals; Molybdenum; Penicillamine; Plutonium; Unithiol | 1982 |
17 other study(ies) available for deferoxamine and chromium
| Article | Year |
|---|---|
[Therapy of poisoning with heavy metals].
Topics: Aminolevulinic Acid; Cadmium Poisoning; Chromium; Deferoxamine; Dimercaprol; Edetic Acid; Ferrocyanides; Humans; Infusions, Parenteral; Iron; Lead Poisoning; Manganese Poisoning; Mercury Poisoning; Occupational Medicine; Penicillamine; Pentetic Acid; Thallium | 1975 |
In vitro competition between ferrichrome and phage for the outer membrane T5 receptor complex of Escherichia coli.
Topics: Aluminum; Binding Sites; Binding, Competitive; Chromium; Coliphages; Deferoxamine; DNA Viruses; Escherichia coli; Ferrichrome; Hydroxamic Acids; Membranes; Peptides, Cyclic; Piperazines | 1975 |
Effects of aluminum(III), chromium(III), and iron(III) on the rate of dissolution of calcium hydroxyapatite crystals in the absence and presence of the chelating agent desferrioxamine.
Topics: Adsorption; Aluminum; Aluminum Chloride; Aluminum Compounds; Chlorides; Chromium; Chromium Compounds; Crystallization; Deferoxamine; Durapatite; Ferric Compounds; Humans; Hydroxyapatites; Nitrates; Solubility; Solutions | 1987 |
Metal complexes of mycobactin P and of desferrisideramines.
Topics: Chromium; Deferoxamine; Electrophoresis; Gallium; Growth Inhibitors; Growth Substances; Hydrogen-Ion Concentration; Hydroxamic Acids; Ion Exchange; Iron; Metals; Mycobacterium; Spectrophotometry; Vanadium | 1969 |
Generation of free radicals from hydrogen peroxide and lipid hydroperoxides in the presence of Cr(III).
Topics: Benzene Derivatives; Chromium; Cyclic N-Oxides; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxides; Hydroxyl Radical; Lipid Peroxides; Pentetic Acid; Peroxides; Spin Labels; tert-Butylhydroperoxide | 1993 |
Synthesis of Cr(IV)-GSH, its identification and its free hydroxyl radical generation: a model compound for Cr(VI) carcinogenicity.
Topics: Carcinogens; Chromates; Chromium; Cyclic N-Oxides; Deferoxamine; Electron Spin Resonance Spectroscopy; Glutathione; Hydrogen Peroxide; Hydroxyl Radical; Oxidation-Reduction; Spin Labels | 1997 |
Effect of microbial siderophores on matrix metalloproteinase-2 activity.
Topics: Bacteria; Calcium Chloride; Chelating Agents; Chlorides; Chromium; Collagen; Connective Tissue; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Extracellular Matrix; Ferric Compounds; Ferrichrome; Gelatinases; Humans; Hydroxybenzoates; Indicators and Reagents; Iron Chelating Agents; Macromolecular Substances; Matrix Metalloproteinase 2; Metalloendopeptidases; Periodontitis; Phenylmercuric Acetate; Phenylpyruvic Acids; Piperazines; Rosaniline Dyes; Siderophores; Sodium Dodecyl Sulfate; Sulfhydryl Reagents | 1999 |
Role of molecular oxygen in the generation of hydroxyl and superoxide anion radicals during enzymatic Cr(VI) reduction and its implication to Cr(VI)-induced carcinogenesis.
Topics: Carcinogenicity Tests; Carcinogens; Chelating Agents; Chromium; Deferoxamine; DNA; DNA Damage; Electron Spin Resonance Spectroscopy; Glutathione Reductase; Hydrogen Peroxide; Hydroxyl Radical; NADP; Oxidation-Reduction; Oxygen; Oxygen Consumption; Superoxides | 2000 |
Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs.
Topics: Animals; Chromium; Deferoxamine; DNA Fragmentation; Electron Spin Resonance Spectroscopy; Electrophoresis; Free Radical Scavengers; Hydroxyl Radical; Iron Chelating Agents; Male; Mice; Potassium Dichromate; Thiourea | 2001 |
Cytochrome b(5) plays a key role in human microsomal chromium(VI) reduction.
Topics: Adenosine Diphosphate; Chlorides; Chromium; Cytochromes b5; Deferoxamine; Ferric Compounds; Humans; Liposomes; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Proteolipids; Recombinant Proteins | 2001 |
Deferoxamine reduces and nitric oxide synthase inhibition increases neutrophil-mediated myotube injury.
Topics: Catalase; CD18 Antigens; Chromium; Chromium Radioisotopes; Culture Media, Conditioned; Deferoxamine; Humans; Hydroxyl Radical; Iron Chelating Agents; Isothiuronium; Luminescent Measurements; Muscle Fibers, Skeletal; Neutrophils; Nitric Oxide Synthase; Reactive Oxygen Species; Superoxide Dismutase | 2003 |
Cross talk between iron metabolism and diabetes.
Topics: Aged; Amino Acids; Arteriosclerosis; Chromium; Cytokines; Deferoxamine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose; Hemochromatosis; Humans; Insulin; Insulin Secretion; Iron; Iron Deficiencies; Nicotinic Acids; Oxidants; Receptors, Transferrin | 2004 |
Pyridine-2,6-bis(thiocarboxylic acid) produced by Pseudomonas stutzeri KC reduces chromium(VI) and precipitates mercury, cadmium, lead and arsenic.
Topics: Arsenic; Cadmium; Carcinogens, Environmental; Chemical Precipitation; Chromium; Deferoxamine; Hydrogen-Ion Concentration; Lead; Mercury; Molecular Structure; Oxidation-Reduction; Pseudomonas stutzeri; Pyridines; Siderophores; Spectrometry, Mass, Electrospray Ionization; Sulfides | 2007 |
Structure-based differences between the metal ion selectivity of two siderophores desferrioxamine B (DFB) and desferricoprogen (DFC): why DFC is much better Pb(II) sequestering agent than DFB?
Topics: Calcium; Cations, Divalent; Chromium; Deferoxamine; Diketopiperazines; Hydroxamic Acids; Lead; Ligands; Magnesium; Metals; Siderophores; Structure-Activity Relationship | 2008 |
Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: role of Cr(VI) chelation.
Topics: Animals; Antidotes; Catalase; Chelating Agents; Chromium; Deferoxamine; Glutathione; In Vitro Techniques; Indicators and Reagents; Kidney; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Male; Oxidative Stress; Potassium Dichromate; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase | 2012 |
Increased Solubility and Bioavailability of Hydroxy-Cr(III) Precipitates in the Presence of Hydroxamate Siderophores.
Topics: Bentonite; Biological Availability; Chromium; Coordination Complexes; Deferoxamine; Piperazines; Soil Pollutants; Solubility; Surface Properties | 2018 |
Chromium removal from aqueous solutions using new silica gel conjugates of desferrioxamine or diethylenetriaminepentaacetic acid.
Topics: Adsorption; Chromium; Deferoxamine; Hydrogen-Ion Concentration; Kinetics; Pentetic Acid; Silica Gel; Solutions; Water Pollutants, Chemical | 2020 |